Amlodipine Besylate-Folic Acid demonstrates superior efficacy to Enalapril Maleate-Folic Acid in treating H-type hypertension
Abstract
OBJECTIVE: This retrospective research was designed to compare the treatment outcomes of H-type hypertension (HTH) patients treated with Amlodipine Besylate-Folic Acid Tablets (Amlo-FA) vs. Enalapril Maleate-Folic Acid Tablets (Ena-FA). METHODS: This investigation comprised 155 HTH cases. The control group was treated with the Ena-FA regimen, while the observation group received Amlo-FA therapy. Patients' clinical data were comparatively analyzed. RESULTS: Compared to controls, the observation group demonstrated superior overall treatment effectiveness (90.48% vs. 71.83%, P=0.003). Following treatment, systolic blood pressure (SBP; (129.86±6.24) mmHg vs. (139.66±8.04) mmHg, P
Fields of Study & Subjects
Blood Pressure and Hypertension Studies
Folate and B Vitamins Research
Cardiovascular Health and Disease Prevention
Publication details
- Journal / source
- American Journal of Translational Research
- Volume
- 18
- Issue
- 2
- Pages
- 1114–1124
- Publication date
- 1 January 2026
- Language
- EN